Patients with a fasciocutaneous, musculo-fasciocutaneouss or osseo-fasciocutaneouss transplant
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Fasciocutaneouss, musculo-fasciocutaneous or osseo-fasciocutaneous transplant Informed Consent
Exclusion criteria
Exclusion criteria: Incapability of the patient in giving an informed consent Dementi or marked cognitive dysfunction Terminal disease with a life expectancy < 12 months Condition after organ transplantation Simultaneous participation in a pharmacological study Pregnancy Implanted insulin pump Implanted pace maker Active Hepatitis B or C infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound healing (appearance, micro-circulatory characterization (parameters inter alia tissue oxygen saturation)) in the vicinity of the transplant donor site. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of quality of life e.g. by decrease of (wound) pain (assessment via the SF-12 questionnaire at the visits V0, V1 and V10) | — |
Countries
Germany
Contacts
Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie